It has been shown that FOXM1 mediated resistance to chemotherapeutic drugs in breast cancer cells.22, 50 Jimmy et al reported that cisplatin‐resistant breast cancer cells could be reversed by the FOXM1 inhibitor thiostrepton.22 We observed that FOXM1 was also up‐regulated in paclitaxel‐resistant cells. Here, FOXM1 is linked to breast carcinoma.